イソニアジド INH



  1. antibacterial drug (trade name Nydrazid) used to treat tuberculosis (同)INH, Nydrazid

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/05/10 07:46:40」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

English Journal

  • Classical against molecular-genetic methods for susceptibility testing of antituberculotics.
  • Porvaznik I1, Mokry J, Solovic I.
  • Advances in experimental medicine and biology.Adv Exp Med Biol.2015;835:15-22. doi: 10.1007/5584_2014_28.
  • Tuberculosis currently belongs to rare respiratory diseases in Slovakia. However, the emergence and spread of multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are major challenges for global tuberculosis control, since the treatment of resistant forms c
  • PMID 25252893
  • Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.
  • Kim HJ1, Seo KA1, Kim HM1, Jeong ES1, Ghim JL1, Lee SH2, Lee YM3, Kim DH4, Shin JG5.
  • Journal of pharmaceutical and biomedical analysis.J Pharm Biomed Anal.2015 Jan;102:9-16. doi: 10.1016/j.jpba.2014.08.026. Epub 2014 Sep 1.
  • A simple and accurate liquid chromatography (LC)-tandem mass spectrometry (MS/MS) method for the quantitation of 20 anti-tuberculosis (anti-TB) drugs in human plasma, was developed as a tool for therapeutic drug monitoring. Two protein precipitation methods were adopted; one using methanol containin
  • PMID 25218029
  • Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy.
  • Narendran G1, Menon PA1, Venkatesan P1, Vijay K1, Padmapriyadarsini C1, Ramesh Kumar S1, Bhavani KP1, Sekar L1, Gomathi SN1, Chandrasekhar C2, Kumar S2, Sridhar R3, Swaminathan S1.
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.Clin Infect Dis.2014 Dec 15;59(12):1798-804. doi: 10.1093/cid/ciu674. Epub 2014 Aug 25.
  • BACKGROUND: Risk factors for acquired rifampicin resistance (ARR) in human immunodeficiency virus (HIV)/tuberculosis coinfection, in the highly active antiretroviral therapy (HAART) era, needs evaluation. We studied the impact of HIV and HAART on ARR among patients taking thrice-weekly antituberculo
  • PMID 25156114

Japanese Journal

  • GenoType MTBDRplusによる多剤耐性結核菌同定に関する検討
  • 近松 絹代,水野 和重,青野 昭男 [他]
  • 結核 86(7), 697-702, 2011-07
  • NAID 40018950982
  • Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan
  • Kozhamkulov Ulan,Akhmetova Ainur,Rakhimova Saule [他]
  • Japanese Journal of Infectious Diseases 64(3), 253-255, 2011-05
  • NAID 40018820944

Related Links

Isoniazid (Laniazid, Nydrazid), also known as isonicotinylhydrazine (or INH), is an organic compound that is the first-line medication in prevention and treatment of tuberculosis. The compound was first synthesized in the early 20th ...
Before taking isoniazid, tell your doctor and pharmacist if you are allergic to isoniazid or any other drugs. tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially ...

Related Pictures

071 300 Pill - isoniazid 300 mgisoniazid) Drug Side Effects Isoniazid Tablet BP 300 Mg ImagePublic Health: Isoniazid (INH)Isoniazid Oral Tablet Drug Information Isoniazid: Indications, Side Effects

拡張検索isoniazid sodium methanesulfonate





isoniazid INH
イソニコチン酸ヒドラジド isonicotinic acid hydrazide INAH


  • 抗結核薬


  • 結核菌の細胞壁を構成するミコール酸の生合成を阻害。



  • イスコチン原末/イスコチン錠100mg


  • 1. Isoniazid hepatotoxicity - uptodate [1]


  [★] イソニアジド isoniazid

isoniazid sodium methanesulfonate」

  [★] イソニアジドメタンスルホン酸ナトリウム